Provided by Tiger Trade Technology Pte. Ltd.

AxoGen

47.10
-1.2000-2.48%
Post-market: 47.100.00000.00%16:15 EDT
Volume:951.25K
Turnover:45.13M
Market Cap:2.53B
PE:-69.54
High:49.06
Open:48.66
Low:46.79
Close:48.30
52wk High:52.91
52wk Low:15.24
Shares:53.66M
Float Shares:52.65M
Volume Ratio:1.19
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6773
EPS(LYR):-0.3410
ROE:-18.21%
ROA:-3.15%
PB:9.86
PE(LYR):-138.12

Loading ...

AxoGen Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 28

AxoGen Q1 revenue beats analyst estimates

Reuters
·
Apr 28

GUIDANCE: (AXGN) Axogen Expects 2026 Revenue $270M, vs. FactSet Est of $266.2M

MT Newswires Live
·
Apr 28

Axogen Q1 FY26 net loss widens to $19.6 million; revenue rises 26.6% to $61.5 million

Reuters
·
Apr 28

AxoGen Shares Jump 16% Premarket After Q1 Revenue Beat

THOMSON REUTERS
·
Apr 28

Stock Track | AxoGen Soars 14.24% in Pre-market on Strong Q1 Earnings Beat and Upbeat Guidance

Stock Track
·
Apr 28

Axogen Q1 Adj. EPS $0.07, Inline, Sales $61.457M Beat $57.725M Estimate

Benzinga Earnings
·
Apr 28

BRIEF-AxoGen Q1 Revenue USD 61.5 Million Vs. IBES Estimate USD 57.7 Million

Reuters
·
Apr 28

AxoGen Inc - Sees 2026 Gross Margin 74%-76%

THOMSON REUTERS
·
Apr 28

AxoGen Inc - Expects to Be Free Cash Flow Positive for Full-Year 2026

THOMSON REUTERS
·
Apr 28

AxoGen Q1 Gross Margin 75.2%

THOMSON REUTERS
·
Apr 28

AxoGen Outlook FY Revenue USD 270 Million

THOMSON REUTERS
·
Apr 28

Axogen, Inc. Reports First Quarter 2026 Financial Results

GlobeNewswire
·
Apr 28

Lake Street Keeps Their Buy Rating on AxoGen (AXGN)

TIPRANKS
·
Apr 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 27

AxoGen price target raised to $45 from $40 at Canaccord

TIPRANKS
·
Apr 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 24

Is Axogen’s Upgraded Outlook And Avance BLA Progress Altering The Investment Case For Axogen (AXGN)?

Simply Wall St.
·
Apr 24

Axogen Is Maintained at Buy by Lake Street

Dow Jones
·
Apr 24

AxoGen Inc : Leerink Partners Raises Target Price to $49 From $43

THOMSON REUTERS
·
Apr 17